Juan Vera
Net worth: 505 751 $ as of 30/06/2026
Net worth: 505 751 $ as of 30/06/2026
Juan F.
Vera was the founder of AlloVir, Inc., founded in 2013, where the title held was Director & Chief Product Development Officer from 2014 to 2020.
Dr. Vera is also the founder of Marker Cell Therapy, Inc...
Dr. Vera currently holds the positions of President, CEO, Secretary, Treasurer & Director at Marker Therapeutics, Inc. since 2018.
Dr. Vera is also an Associate Professor at Baylor College of Medicine since 2015.
The education history includes a doctorate degree from Universidad El Bosque.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/03/2026 | 344,048 ( 2.06% ) | 505 751 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Chief Executive Officer | 01/05/2023 |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2004 |
| Companies | Position | End |
|---|---|---|
Marker Cell Therapy, Inc.
Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops clinical stage immuno-oncology therapies | Founder | - |
| ALLOVIRPAR | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlloVir, Inc.
AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Marker Cell Therapy, Inc.
Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops clinical stage immuno-oncology therapies | Commercial Services |
Universidad El Bosque
Universidad El Bosque Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions